{"id":"https://openalex.org/W2600516765","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","title":"An international phase 3 randomized, placebo-controlled study of CC-486 (oral azacitidine) maintenance therapy in patients with acute myeloid leukemia (AML) in complete remission (CR): The Quazar AML maintenance trial.","display_name":"An international phase 3 randomized, placebo-controlled study of CC-486 (oral azacitidine) maintenance therapy in patients with acute myeloid leukemia (AML) in complete remission (CR): The Quazar AML maintenance trial.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2600516765","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","mag":"2600516765"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.tps7097","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail J. Roboz","raw_affiliation_strings":["Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037134717","display_name":"Dominik Selleslag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dominik Selleslag","raw_affiliation_strings":["AZ Sint-Jan, Brugge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AZ Sint-Jan, Brugge, Belgium","institution_ids":["https://openalex.org/I4210123377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003682435","display_name":"Pau Montesinos","orcid":"https://orcid.org/0000-0002-3275-5593","observed_orcids":["https://orcid.org/0000-0002-3275-5593"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pau Montesinos","raw_affiliation_strings":["Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005591514","display_name":"Andrew H. Wei","orcid":"https://orcid.org/0000-0002-7514-3298","observed_orcids":["https://orcid.org/0000-0002-7514-3298"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Wei","raw_affiliation_strings":["The Alfred Hospital, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Alfred Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I2801993434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050873337","display_name":"Kimmo Porkka","orcid":"https://orcid.org/0000-0003-4112-5902","observed_orcids":["https://orcid.org/0000-0003-4112-5902"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Kimmo Porkka","raw_affiliation_strings":["HUCH Cancer Center, Department of Hematology, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HUCH Cancer Center, Department of Hematology, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024529604","display_name":"Ant\u00f4nio-Carlos G. de Almeida","orcid":"https://orcid.org/0000-0003-4893-338X","observed_orcids":["https://orcid.org/0000-0003-4893-338X"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Antonio Almeida","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa de Francisco Gentil, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa de Francisco Gentil, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051485142","display_name":"Sanjay Ram Mohan","orcid":"https://orcid.org/0000-0002-6715-6697","observed_orcids":["https://orcid.org/0000-0002-6715-6697"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjay Ram Mohan","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019086598","display_name":"Jose Francisco Falantes","orcid":"https://orcid.org/0000-0001-8660-7038","observed_orcids":["https://orcid.org/0000-0001-8660-7038"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose F Falantes","raw_affiliation_strings":["Hospital Universitario Virgen del Rocio, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Rocio, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063825892","display_name":"Maria Teresa Voso","orcid":"https://orcid.org/0000-0002-6164-4761","observed_orcids":["https://orcid.org/0000-0002-6164-4761"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Teresa Voso","raw_affiliation_strings":["Universita Cattolica del Sacro Cuore, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universita Cattolica del Sacro Cuore, Rome, Italy","institution_ids":["https://openalex.org/I103320735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103909351","display_name":"Keshava Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keshava Kumar","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022044905","display_name":"Frederic Camus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederic Camus","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064895172","display_name":"Ignazia La Torre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ignazia La Torre","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111658759","display_name":"Barry Skikne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry Skikne","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"TPS7097","last_page":"TPS7097"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.9520000219345093},{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9559999704360962},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9440000057220459},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7429999709129333},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8270000219345093},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8820000290870667},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6200000047683716},{"id":"https://openalex.org/keywords/cytogenetic-risk","display_name":"cytogenetic risk","score":0.5379999876022339},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8199999928474426},{"id":"https://openalex.org/keywords/home-based-treatment","display_name":"home-based therapy","score":0.31200000643730164},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9221619367599487},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.631323516368866},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.6011637449264526},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5912308096885681},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.537710428237915},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48734959959983826},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4698666036128998},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.4538111686706543},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4331163167953491},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3578009009361267},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3530406355857849},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35299575328826904},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.tps7097","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps7097","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2989764345","https://openalex.org/W2260812679","https://openalex.org/W3114952208","https://openalex.org/W3032582141","https://openalex.org/W3097014108","https://openalex.org/W2999169540","https://openalex.org/W3095309665","https://openalex.org/W3095097856","https://openalex.org/W3198012976","https://openalex.org/W4283362445"],"abstract_inverted_index":{"TPS7097":[0],"Background:":[1],"Few":[2],"inroads":[3],"have":[4],"been":[5,334],"made":[6],"in":[7,17,30,53,78,82,167,187,287],"the":[8],"past":[9],"30":[10],"years":[11],"to":[12,45,153,185,203,257,260,303,311],"improve":[13,138],"overall":[14],"survival":[15,134],"(OS)":[16],"older":[18,33,54,168],"patients":[19],"(pts)":[20],"with":[21,56,104,170,178,196,290],"AML.":[22,171],"While":[23],"induction":[24],"chemotherapy":[25],"(IC)":[26],"can":[27,164,243],"induce":[28],"CR":[29,189],"40-50%":[31],"of":[32,76,90,125,140,213,271,282,293],"pts,":[34,114],"most":[35],"relapse":[36],"within":[37],"3-18":[38],"months.":[39],"Post-remission":[40],"therapy":[41],"(Tx)":[42],"is":[43,72,102,111,151,157,218,250,301],"required":[44],"prevent":[46],"relapse.":[47],"Parenteral":[48],"azacitidine":[49],"(AZA)":[50],"prolonged":[51,99],"OS":[52,166,319],"pts":[55,169,242,295,332],"AML":[57,146,181,183],"vs":[58,63],"conventional":[59],"care":[60],"regimens":[61],"(10.4":[62],"6.5":[64],"months,":[65],"P=":[66],"0.1009)":[67],"(Dombret,":[68],"Haematologica,":[69],"2014:LB2433).":[70],"CC-486":[71,107,129,156,207],"an":[73,158],"oral":[74,86],"formulation":[75,87],"AZA":[77,91],"development":[79],"for":[80,113,210,307],"use":[81],"hematologic":[83],"malignancies.":[84],"An":[85],"allows":[88],"delivery":[89],"at":[92,109,233],"lower":[93],"systemic":[94],"doses":[95],"over":[96],"a":[97,132,291,313],"more":[98],"schedule":[100],"than":[101],"practical":[103],"SC":[105],"AZA.":[106],"taken":[108],"home":[110],"convenient":[112],"eliminates":[115],"injection-":[116],"and":[117,120,137,227,237,262,268],"catheter-site":[118],"reactions,":[119],"avoids":[121],"resource":[122],"utilization":[123],"costs":[124],"hospital/clinic":[126],"visits.":[127],"Thus,":[128],"may":[130,279],"offer":[131],"relapse-free":[133],"(RFS)":[135],"advantage":[136],"quality":[139],"life.":[141],"The":[142,247],"Quazar":[143],"phase":[144],"3":[145],"Maintenance":[147],"trial":[148,342],"(clinicaltrials.gov":[149],"NCT01757535)":[150],"designed":[152,302],"assess":[154,266],"whether":[155],"effective":[159],"low-intensity":[160],"maintenance":[161,276],"Tx":[162,277],"that":[163,278],"extend":[165],"Methods:":[172],"Pts":[173],"aged":[174],"\u2265":[175,224,308],"55":[176],"yrs":[177],"de":[179],"novo":[180],"or":[182,190,197,208],"secondary":[184],"MDS":[186],"first":[188],"CRi":[191],"(IWG":[192],"2003)":[193],"after":[194],"IC,":[195],"without":[198],"consolidation,":[199],"are":[200],"randomized":[201],"1:1":[202],"300":[204],"mg":[205],"QD":[206],"placebo":[209],"14":[211],"days":[212],"28-day":[214],"treatment":[215,316],"cycles.":[216],"Randomization":[217],"stratified":[219],"by":[220],"age":[221],"(55-64":[222],"/":[223,231],"65":[225],"yrs)":[226],"cytogenetic":[228],"risk":[229],"(Intermediate":[230],"Poor)":[232],"induction,":[234],"prior":[235],"MDS,":[236],"post-remission":[238],"consolidation":[239],"Tx.":[240],"All":[241],"receive":[244],"supportive":[245],"care.":[246],"primary":[248],"endpoint":[249],"OS.":[251],"Secondary":[252],"endpoints":[253],"include":[254],"RFS,":[255],"time":[256,259],"relapse,":[258],"discontinuation,":[261],"safety.":[263],"Exploratory":[264],"analyses":[265],"molecular":[267],"cellular":[269],"markers":[270],"minimal":[272],"residual":[273],"disease":[274],"during":[275],"be":[280],"predictive":[281],"clinical":[283],"outcomes.":[284],"Enrollment":[285],"began":[286],"May":[288],"2013,":[289],"target":[292],"460":[294],"from":[296],"150":[297],"global":[298],"sites.":[299],"Accrual":[300],"allow":[304],"enough":[305],"events":[306],"90%":[309],"power":[310],"detect":[312],"statistically":[314],"significant":[315],"effect":[317],"on":[318],"(n":[320],"=":[321],"330":[322],"deaths;":[323],"expected":[324],"duration":[325],"60":[326],"months).":[327],"By":[328],"Jan":[329],"2015,":[330],"168":[331],"had":[333],"randomized.":[335],"Study":[336],"enrollment":[337],"continues":[338],"through":[339],"2016.":[340],"Clinical":[341],"information:":[343],"NCT01757535.":[344]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2017-04-07T00:00:00"}